Search

everythinglearnresearchcommunity

for

Search:↓

Miniaturized hairs stay connected to muscle in alopecia areata, allowing possible regrowth, but not in androgenetic alopecia.

Twice-weekly 5 mg betamethasone helps hair regrowth in alopecia areata.

People with Down syndrome are more likely to have alopecia areata and need regular skin check-ups.

Applying latanoprost on skin can stimulate hair growth with minimal side effects.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Squaric acid dibutylester effectively treats alopecia areata.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Vitamin B12, folate, ferritin, and iron levels are not linked to alopecia areata.

Travoprost can help eyelash growth but may cause darkening around the eyes.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.